The New Board of SFEE

Press Release

Halandri, April 3, 2012

On March 30, 2012 the new Board of SFEE determined the areas of responsibility of the Vice Presidents and its members.

President:
Frouzis Konstantinos (Novartis)

Vice Presidents – Areas of Responsibility:
Apostolides Pascal (ABBOTT Laboratories)
• Reimbursement – Lists – EOPYY
Vlontzos Yiannis (MERCK)
• Scientific and Regulatory Affairs – EOF
Evripides Costas (GENESIS Pharma)
• Financial Affairs, Bonds & NHS Debts
Katzourakis George (GLAXOSMITHKLINE)
• Cooperation with EFPIA, Troika, IMF
Kefalas Nikos (JANSSEN – CILAG Pharmaceutical)
• Pricing and New Products
Panagoulias Costas (VIAN)
• Development of Domestic Production
• Industry’s Economic & Social Contribution

Secretary General
Niadas Vasilis (CANA)
• Strategic Planning – Monitoring of Healthcare Expenditure – Documentation

Treasurer:
Varelas Nicholas (Galenica)

Members: Gerassopoulos Marcos (Sanofi), Gkiouleka Athanasia (UCB), Economou Costas (Boehringer Ingelheim), Filiotis Spyros (Pharmaserve – Lilly), Katsikas Marios (Rottapharm), Kosmidis Marios (WinMedica)